Earlier quoted context omitted.
I particularly like the rant on pharmaceuticals companies lack of basic research. My impression has been that medical progression have been slow for quite some time, nice to see that there are some truth to that. In the end software and tech companies might just eat up the pharmaceutical industry as well. - It's all just code at some level. The Deepmind team did this with ; "We trained this system on publicly availab…
> So it wasn't out of reach for academia, pharmaceuticals, or others with a bit of resources. How much does hiring a deepmind-like team cost though? (massively more than the TPU resources?) Still within reach of pharmaceutical industry I guess, but maybe not so easy for academia.
AlphaFold: a solution to a 50-year-old grand challenge in biology
421–430 of 683 posts
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#422Earlier quoted context omitted.
> Are there any cases where ML performed decently but then hit a ceiling while expert systems kept improving? Yes, this describes entire history of AI including several boom-bust cycles. In particular the 80's come to mind. Yes the practitioners think that there's no technical barriers stopping them from eating the world, but that's exactly what people thought about other so-called revolutionary advances. Although to…
I think the disconnect this time around is in productionization. We're getting breakthroughs in a wide range of problems, and translating those gains in the problem space into 'real' stable, practical solutions we can use in the world is the remaining gap, and often takes years of additional effort. It's still really expensive to launch this stuff, and often requires domain expertise that the ML research team doesn't…
Or when you drive your car, think about the lights-out factory that built-it, using robotics technologies developed in the 80's and 90's, and the freeways which largely operate without choke points again due to expert system models used by city planners.
These advances were just as revolutionary before, and people were just as excited about AI technologies eating the world. Still, it largely didn't happen. To continue the example of robotics, we don't have an equivalent of the Jetson's home robot Rosey. We can make a robot assemble a $50,000 car, but we can't get it to fold the laundry.
These rapid successes you see aren't literally "any problem from any field" -- it's specific problems chosen specifically for their likely ease in solving using current methods. DeepMind didn't decide to take on protein folding at random; they looked around and picked a problem that they thought they could solve. Don't expect them to have as much success on every problem they put their minds to.
No, machine learning is not trivially solving the hardest problems in every field. Not even close. In biomedicine, for example, protein folding is probably one of the easiest challenges. It's a hard problem, yes, but it's self-contained: given an amino acid sequence, predict the structure. Unlike, say, predicting the metabolism of a drug applied to a living system, which requires understanding an extremely dense network of existing metabolic pathways and their interdependencies on local cell function. There's no magic ML pixie dust that can make that hard problem go away.
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#423I wonder if we can determine if this extends to proteins that aren't as keen to determining their 3D structure?
For example, certain proteins are more crystallizable than others.. For these non-crystallizable proteins, I wonder if we can say that AlphaFold would generate accurate 3D models? And if possible, might there be a way to map out this uncertainty?
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#424So, sorry to be a philistine but what specific discoveries will this lead to... will it make it easier to produce antivirals or even molecular machines?
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#425A few times, I get immense pangs of jealousy for younger people a generation or a half before me. And I'm only 30! This is one of those times.
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#426Earlier quoted context omitted.
The industry process will not change. You still need industrial biologists to generate and validate AphaFold structures, interpret the results as part of the bigger picture, and to finally design the drugs. And, then, of course you still need to validate the drugs in experimental systems (first the test tube, then mice, then humans). So your second guess is correct - one of the steps is much cheaper now, which margin…
> "armies of students who routinely spend 4-6 years of their PhD trying to solve a structure of a single protein" Back in the 1990s, when I worked on structure data, I remember that at least some crystallizations were easy enough they could be done as a rotation project. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287266/ suggests that life is now a lot easier than the 1990s. Quoting the abstract: > Macromolecular…
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#427Earlier quoted context omitted.
> The price of training the final architecture is meaningless. The research is the giant shoulders you stand on, the compute cost is the price of the tool you need to do the present-day work. Both are relevant but the shoulder’s of giants are generally more accessible, particularly if we’re talking about published research and not proprietary tech. A competing team is not starting from the same place the DeepMind tea…
To expand on this, after fully reading AlQuraishi's "What Just Happened" post from a couple years ago, was this point that he made; > I don’t think we would do ourselves a service by not recognizing that what just happened presents a serious indictment of academic science. There are dozens of academic groups, with researchers likely numbering in the (low) hundreds, working on protein structure prediction. We have bee…
If you were trying to get across the Atlantic, this would be like getting upset at a group of bridgebuilders for trying to solve the problem by building a bridge across instead of by inventing the airplane. The approaches are that different.
Re: AlphaFold: a solution to a 50-year-old grand challenge in biology
#428Fascinating! AlphaFold (and other competitors) seem to use MSA (Multiple Sequence Aligment) and this (brilliant) idea of co-evolving residues to build an initial graph of sections of protein chain that are likely proximal. This seems like a useful trick for predicting existing biological structures (i.e. ones that evolved) from genomic data. I wonder (as very much a non-biologist), do MSA-based approaches also help u…
Not really. MSA-based approaches, as most structure prediction methods, have as a goal to find the lowest energy conformation of the protein chain, disregarding folding kinetics and basically all dynamic aspects of protein structure.
> If I write a random genetic sequence (think drug discovery) that has many aligned sequences, without the strong assumption of co-evolution at my disposal, there does not seem any good reason for the aligned sequences to also be proximal.
I don't think I fully understood this, but I'll give it a shot anyway. If your artificial sequence aligns with others, there's a chance that it will fold like them, depending on the quality and accuracy of the multiple sequence alignment. Since multiple sequence alignments are built under the assumption of homology (all sequences have a common ancestor), it's a matter of how far from the "sequence sampling space" your sequence is located compared to the others.